TITLE

Cardiovascular protection in type 2 diabetes: time to ADVANCE management ACCORDing to the evidence

AUTHOR(S)
Hajhosseiny, Reza; Khavandi, Kaivan; Mashayekhi, Soudeh; Greenstein, Adam S.; Malik, Rayaz A.
PUB. DATE
January 2014
SOURCE
Research Reports in Clinical Cardiology;2014, Vol. 5, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Individuals with type 2 diabetes mellitus are at very substantial risk of cardiovascular disease, and most will succumb to complications from premature coronary artery events. At the same time, the diabetic myocardium undergoes unique phenotypic alterations as a consequence of multiple structural and cellular injuries, which together form "diabetic cardiomyopathy." Attempts to curb risk through intensive modulation of glycemia and blood pressure have proven disappointing in preventing cardiovascular events, and potentially even dangerous. Conversely, prior to development of disease, there appears to be a linear relationship between risk parameters and events. These observations are likely the consequence of widespread vascular damage, which is present at the point that glycemic thresholds meet diagnostic criteria for diabetes. This is particularly true of the microcirculation. Interventions at the prediabetic stage have been consistent with this, where early intensive risk-factor modulation has been successful in preventing events and even regressing existing risk. Upstream, the force driving these pathologies is being overweight and obesity. High-risk individuals can be identified through simple body mass parameters, with confirmation of prediabetes/metabolic syndrome with further assessment of other metabolic parameters such as glucose and lipids. A number of novel pharmacotherapies may prove beneficial at this stage, and incretin-based therapies appear particularly promising in this respect. Similarly, bariatric procedures have shown remarkable improvements in metabolic and cardiovascular outcomes, but are clearly unsuitable as a population-wide strategy. Therapeutic lifestyle change and diet have consistently shown efficacy in reversing dysglycemia, lowering blood pressure, and optimizing cholesterol profiles. However, the longevity of these improvements is often limited, and alternative approaches therefore need to be considered. With an evolving and increasingly sophisticated evidence base for nutritional interventions, there is a clear window of opportunity to rescue these individuals from the clinical sequelae of diabetes and consequent cardiovascular complications.
ACCESSION #
94751980

 

Related Articles

  • Metabolic syndrome in an elite African community. Emma-Okon, B. O.; Onayade, A. A.; Adegoke, A. O. // African Journal of Diabetes Medicine;Nov2013, Vol. 21 Issue 2, p42 

    Metabolic syndrome is a combination of metabolic disorders which increase the risk of developing cardiovascular disease and type 2 diabetes, two common causes of morbidity and mortality all over the world, with increasing incidence in sub-Saharan Africa. This study was carried out to determine...

  • Ghrelin in Diabetes and Metabolic Syndrome. Pulkkinen, Leena; Ukkola, Olavi; Kolehmainen, Marjukka; Uusitupa, Matti // International Journal of Peptides;2010, p1 

    Metabolic syndrome is a cluster of related risk factors for cardiovascular disease, type 2 diabetes and liver disease. Obesity, which has become a global public health problem, is one of the major risk factors for development of metabolic syndrome and type 2 diabetes. Obesity is a complex...

  • Pathophysiology of Platelet Resistance to Anti-Aggregating Agents in Insulin Resistance and Type 2 Diabetes: Implications for Anti-Aggregating Therapy. Anfossi, Giovanni; Trovati, Mariella // Cardiovascular & Hematological Agents in Medicinal Chemistry;2006, Vol. 4 Issue 2, p111 

    The insulin resistance syndrome, which presents among its many facets obesity and type 2 diabetes mellitus, is a major risk factor for cardiovascular events. Thus, therapeutic guidelines recommend multifactorial treatment programs including, especially in the presence of type 2 diabetes,...

  • Current Hypertension Reviews, Hot Topics "Obesity, Hypertension, and the Metabolic Syndrome". Masuo, Kazuko // Current Hypertension Reviews;May2010, Vol. 6 Issue 2, p72 

    No abstract available.

  • 16. Cardiovascular risk and the management of dyslipidaemia in patients with type 2 diabetes mellitus.  // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Jun2012, Vol. 17 Issue 2, pS57 

    The article discusses the risk of cardiovascular disease (CVD) and the management of dyslipidaemia in patients with type 2 diabetes mellitus. It states that CVD risk factors in diabetic patients include chronic hyperglycaemia, dyslipidaemia and the metabolic syndrome or insulin resistance...

  • METABOLIC SYNDROME. Donhoffer, Hilda A.; Chan, Y. Michael; Radomski, Manny W. // Wellness Options;2006, Issue 28, p21 

    The article focuses on metabolic syndrome. The condition is associated with high triglyceride and low HDL-cholesterol levels, insulin resistance or type 2 diabetes, elevated blood pressure, obesity, and a higher risk of developing cardiovascular disease. The article discusses the International...

  • A Survey on the Relationship of Metabolic Syndrome Components and the Number of Blood Cells Using Count Data Regression Model. Hassanzadeh, Fatemeh; Iraj Kazemi; Kelishadi, Roya // Journal of Isfahan Medical School;4/4/2011, Vol. 29 Issue 125, p1 

    Background: The metabolic syndrome is characterized by a group of metabolic risk factors at increased risk of coronary heart disease and type 2 diabetes. Obese children with metabolic syndrome have at least three of these risk factors. Since the lifestyle changed resulting in the obesity of...

  • Cardiovascular Disease Risk Factors in Youth With Type 1 and Type 2 Diabetes: Implications of a Factor Analysis of Clustering. Elizabeth J. Mayer-Davis; Bo Ma; Andrew Lawson; Ralph B. D’Agostino Jr.; Angela D. Liese; Ronny A. Bell; Dana Dabelea; Lawrence Dolan; David J. Pettitt; Beatriz L. Rodriguez; Desmond Williams // Metabolic Syndrome & Related Disorders;Apr2009, Vol. 7 Issue 2, p89 

    Background:The extent to which cardiovascular disease (CVD) risk factors cluster in youth with a diagnosis of type 1 (T1DM) or type 2 diabetes mellitus (T2DM) is unclear. Therefore, we aimed to evaluate potential clustering of traditional CVD risk factors that may reflect an unmeasured but...

  • Chronic Kidney Disease Has a More Powerful Impact on Peripheral Arterial Disease Than Metabolic Syndrome in Japanese Type 2 Diabetic Patients. Tsunoda, Keiko; Shimajiri, Yoshinori; Morita, Shuhei; Furuta, Machi; Kadoya, Yoshiki; Yamada, Shoichi; Nanjo, Kishio; Sanke, Tokio // Metabolic Syndrome & Related Disorders;Aug2009, Vol. 7 Issue 4, p323 

    Background:Chronic kidney disease (CKD) and metabolic syndrome have been recognized as risk factors for cardiovascular disease. However, there is no information comparing their impact on macroangiopathy in diabetic patients. Thus, we studied the prevalence of CKD and metabolic syndrome in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics